Findings on Type 2 Diabetes Detailed by Investigators at New Jersey Institute of Technology (Comparison of Sglt1, Sglt2, and Dual Inhibitor Biological Activity In Treating Type 2 Diabetes Mellitus)

Press/Media: Press / Media

Period	Oct 26 2023

Media coverage

Title	Findings on Type 2 Diabetes Detailed by Investigators at New Jersey Institute of Technology (Comparison of Sglt1, Sglt2, and Dual Inhibitor Biological Activity In Treating Type 2 Diabetes Mellitus)
Media name/outlet	Clinical Trials Daily
Country/Territory	United States
Date	10/26/23
Persons	Vivek Kumar